Literature DB >> 10632627

The role of astrocytes and noradrenaline in neuronal glucose metabolism.

M Fillenz1, J P Lowry, M G Boutelle, A E Fray.   

Abstract

In the classical model the energy requirements during neuronal activation are provided by the delivery of additional glucose directly into the extracellular compartment that results from the increase in local cerebral blood flow (rCBF). The present review proposes that astrocytes play a key role in the response to neuronal activation. Arginine for the synthesis of NO, which has a major role in the increase in rCBF, is released from astrocytes in response to stimulation of astrocytic glutamate receptors. The increased delivery of glucose by the blood stream enters astrocytes, where some of it is converted to glycogen. During neuronal activation there is a decrease in extracellular glucose owing to increased utilization followed by a delayed increase; this results from stimulation of astrocytic beta-adrenergic receptors, which leads to a breakdown of glycogen and the export of glucose.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10632627     DOI: 10.1046/j.1365-201x.1999.00578.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  30 in total

1.  Rate of fall in blood glucose and recurrent hypoglycemia affect glucose dynamics and noradrenergic activation in the ventromedial hypothalamus.

Authors:  Meredith B Barnes; Marcus A Lawson; J Lee Beverly
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-28       Impact factor: 3.619

2.  Sex differences in forebrain estrogen receptor regulation of hypoglycemic patterns of counter-regulatory hormone secretion and ventromedial hypothalamic nucleus glucoregulatory neurotransmitter and astrocyte glycogen metabolic enzyme expression.

Authors:  A S M Hasan Mahmood; M M Uddin; M M H Ibrahim; S K Mandal; H N Alhamami; K P Briski
Journal:  Neuropeptides       Date:  2018-10-26       Impact factor: 3.286

3.  Brain energy metabolism and intracranial pressure in idiopathic adult hydrocephalus syndrome.

Authors:  A Agren-Wilsson; A Eklund; L-O D Koskinen; A T Bergenheim; J Malm
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

Review 4.  Adrenergic pharmacology and cognition: focus on the prefrontal cortex.

Authors:  Brian P Ramos; Amy F T Arnsten
Journal:  Pharmacol Ther       Date:  2006-12-28       Impact factor: 12.310

5.  Norepinephrine regulation of ventromedial hypothalamic nucleus metabolic transmitter biomarker and astrocyte enzyme and receptor expression: Impact of 5' AMP-activated protein kinase.

Authors:  Mostafa M H Ibrahim; Hussain N Alhamami; Karen P Briski
Journal:  Brain Res       Date:  2019-01-07       Impact factor: 3.252

6.  Cultured astrocytes do not release adenosine during hypoxic conditions.

Authors:  Takumi Fujita; Erika K Williams; Tina K Jensen; Nathan A Smith; Takahiro Takano; Kim Tieu; Maiken Nedergaard
Journal:  J Cereb Blood Flow Metab       Date:  2011-10-12       Impact factor: 6.200

7.  β2-adrenergic receptor and astrocyte glucose metabolism.

Authors:  Jun-hong Dong; Xin Chen; Min Cui; Xiao Yu; Qi Pang; Jin-peng Sun
Journal:  J Mol Neurosci       Date:  2012-03-08       Impact factor: 3.444

8.  Hindbrain Estrogen Receptor Regulation of Ventromedial Hypothalamic Glycogen Metabolism and Glucoregulatory Transmitter Expression in the Hypoglycemic Female Rat.

Authors:  Prabhat R Napit; Md Haider Ali; Manita Shakya; Santosh K Mandal; Khaggeswar Bheemanapally; A S M Hasan Mahmood; Mostafa M H Ibrahim; K P Briski
Journal:  Neuroscience       Date:  2019-05-12       Impact factor: 3.590

9.  Diffusion of D-glucose measured in the cytosol of a single astrocyte.

Authors:  Marko Kreft; Miha Lukšič; Tomaž M Zorec; Mateja Prebil; Robert Zorec
Journal:  Cell Mol Life Sci       Date:  2012-12-08       Impact factor: 9.261

10.  Beta2 adrenergic agonist, clenbuterol, enhances working memory performance in aging animals.

Authors:  Brian P Ramos; Leslie A Colgan; Eric Nou; Amy F T Arnsten
Journal:  Neurobiol Aging       Date:  2007-03-23       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.